Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Conditions: HIV Infections; Weight Gain Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Pitavastatin 4 Mg Oral Tablet; Drug: Rosuvastatin and Ezetimibe; Drug: Placebo Sponsors: Kirby Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
Conditions: Lipidemia; Coronary Artery Disease; Plaque, Atherosclerotic Interventions: Drug: obicetrapib 10 mg + ezetimibe 10 mg FDC daily; Other: Placebo Sponsors: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
Conditions: Peripheral Artery Disease; Polyvascular Disease Interventions: Drug: Combination therapy of high-intensity dose rosuvastatin and ezetimibe; Drug: Rosuvastatin monotherapy for treat-to-target Sponsors: Yonsei University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Dyslipidemias; Primary Prevention Interventions: Drug: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg; Drug: Mono drug group of Rosuvastatin 20 mg Sponsors: Saint Vincent ' s Hospital, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe
Condition: Healthy Volunteer Study Intervention: Drug: Obicetrapib, 10 mg and Ezetimibe, 10 mg FDC Sponsor: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe
Condition: Healthy Volunteer Study Intervention: Drug: Fixed-Dose Combination (FDC) Tablet Sponsor: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe
Conditions: Healthy Volunteer Study Interventions: Drug: Fixed-Dose Combination (FDC) Tablet Sponsors: NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women
Condition: Healthy Lactating Women Interventions: Drug: Bempedoic Acid 180 MG Oral Tablet; Drug: Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet Sponsor: Esperion Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
